These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 30726758)

  • 21. Fibroblast growth factor-21, energy balance and obesity.
    Giralt M; Gavaldà-Navarro A; Villarroya F
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():66-73. PubMed ID: 26415590
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FGF21 analogs of sustained action enabled by orthogonal biosynthesis demonstrate enhanced antidiabetic pharmacology in rodents.
    Mu J; Pinkstaff J; Li Z; Skidmore L; Li N; Myler H; Dallas-Yang Q; Putnam AM; Yao J; Bussell S; Wu M; Norman TC; Rodriguez CG; Kimmel B; Metzger JM; Manibusan A; Lee D; Zaller DM; Zhang BB; DiMarchi RD; Berger JP; Axelrod DW
    Diabetes; 2012 Feb; 61(2):505-12. PubMed ID: 22210323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibroblast growth factor 21: a regulator of metabolic disease and health span.
    Xie T; Leung PS
    Am J Physiol Endocrinol Metab; 2017 Sep; 313(3):E292-E302. PubMed ID: 28559437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FGF21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss.
    Owen BM; Ding X; Morgan DA; Coate KC; Bookout AL; Rahmouni K; Kliewer SA; Mangelsdorf DJ
    Cell Metab; 2014 Oct; 20(4):670-7. PubMed ID: 25130400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FGF21 does not require interscapular brown adipose tissue and improves liver metabolic profile in animal models of obesity and insulin-resistance.
    Bernardo B; Lu M; Bandyopadhyay G; Li P; Zhou Y; Huang J; Levin N; Tomas EM; Calle RA; Erion DM; Rolph TP; Brenner M; Talukdar S
    Sci Rep; 2015 Jul; 5():11382. PubMed ID: 26153793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibroblast growth factor 21 reverses suppression of adiponectin expression via inhibiting endoplasmic reticulum stress in adipose tissue of obese mice.
    Guo Q; Xu L; Liu J; Li H; Sun H; Wu S; Zhou B
    Exp Biol Med (Maywood); 2017 Feb; 242(4):441-447. PubMed ID: 27811171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel insights into the cardio-protective effects of FGF21 in lean and obese rat hearts.
    Patel V; Adya R; Chen J; Ramanjaneya M; Bari MF; Bhudia SK; Hillhouse EW; Tan BK; Randeva HS
    PLoS One; 2014; 9(2):e87102. PubMed ID: 24498293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FGF21 in obesity and cancer: New insights.
    Lu W; Li X; Luo Y
    Cancer Lett; 2021 Feb; 499():5-13. PubMed ID: 33264641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A review of fibroblast growth factor 21 in diabetic cardiomyopathy.
    Zhang X; Yang L; Xu X; Tang F; Yi P; Qiu B; Hao Y
    Heart Fail Rev; 2019 Nov; 24(6):1005-1017. PubMed ID: 31175491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibroblast growth factor 21 night watch: advances and uncertainties in the field.
    Kharitonenkov A; DiMarchi R
    J Intern Med; 2017 Mar; 281(3):233-246. PubMed ID: 27878865
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential roles of fibroblast growth factor 21 in the brain.
    Sa-Nguanmoo P; Chattipakorn N; Chattipakorn SC
    Metab Brain Dis; 2016 Apr; 31(2):239-48. PubMed ID: 26738728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated Fibroblast growth factor 21 (FGF21) in obese, insulin resistant states is normalised by the synthetic retinoid Fenretinide in mice.
    Morrice N; Mcilroy GD; Tammireddy SR; Reekie J; Shearer KD; Doherty MK; Delibegović M; Whitfield PD; Mody N
    Sci Rep; 2017 Mar; 7():43782. PubMed ID: 28256636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased fibroblast growth factor 21 expression in high-fat diet-sensitive non-human primates (Macaca mulatta).
    Nygaard EB; Møller CL; Kievit P; Grove KL; Andersen B
    Int J Obes (Lond); 2014 Feb; 38(2):183-91. PubMed ID: 23736354
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FGF19 and FGF21 serum concentrations in human obesity and type 2 diabetes behave differently after diet- or surgically-induced weight loss.
    Gómez-Ambrosi J; Gallego-Escuredo JM; Catalán V; Rodríguez A; Domingo P; Moncada R; Valentí V; Salvador J; Giralt M; Villarroya F; Frühbeck G
    Clin Nutr; 2017 Jun; 36(3):861-868. PubMed ID: 27188262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibroblast growth factor 21: effects on carbohydrate and lipid metabolism in health and disease.
    Kralisch S; Fasshauer M
    Curr Opin Clin Nutr Metab Care; 2011 Jul; 14(4):354-9. PubMed ID: 21505329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.
    Xu J; Stanislaus S; Chinookoswong N; Lau YY; Hager T; Patel J; Ge H; Weiszmann J; Lu SC; Graham M; Busby J; Hecht R; Li YS; Li Y; Lindberg R; Véniant MM
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1105-14. PubMed ID: 19706786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietary induction of obesity and insulin resistance is associated with changes in Fgf21 DNA methylation in liver of mice.
    Geißler C; Krause C; Neumann AM; Britsemmer JH; Taege N; Grohs M; Kaehler M; Cascorbi I; Lewis AG; Seeley RJ; Oster H; Kirchner H
    J Nutr Biochem; 2022 Feb; 100():108907. PubMed ID: 34801693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity is a fibroblast growth factor 21 (FGF21)-resistant state.
    Fisher FM; Chui PC; Antonellis PJ; Bina HA; Kharitonenkov A; Flier JS; Maratos-Flier E
    Diabetes; 2010 Nov; 59(11):2781-9. PubMed ID: 20682689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FGF21 signaling in glutamatergic neurons is required for weight loss associated with dietary protein dilution.
    Flippo KH; Jensen-Cody SO; Claflin KE; Potthoff MJ
    Sci Rep; 2020 Nov; 10(1):19521. PubMed ID: 33177640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Whole transcriptome analysis and validation of metabolic pathways in subcutaneous adipose tissues during FGF21-induced weight loss in non-human primates.
    Murray SA; Dalbøge LS; Baquero K; Sanford CA; Misquith A; Mercer AJ; Meek TH; Guldbrandt M; Andersen B; Kievit P; Grove KL; Kutlu B
    Sci Rep; 2020 Apr; 10(1):7287. PubMed ID: 32350364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.